Prevalence and Clinicopathologic Features of Mucinous Cystic Tumor and Intraductal Papillary Mucinous Tumor of Pancreas in Korea

Background : Mucin producing cystic neoplasms, such as mucinous cystic tumor (MCT) and intraductal papillary mucinous tumor (IPMT) of the pancreas, are uncommon but become increasing in their incidences. The pathologic classification and biologic potential of these neoplasms remain the subject of controversy. Methods : The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists analyzed the clinicopathologic characteristics of 85 cases of MCT and 72 cases of IPMT and examined the expression patterns of p53, CEA and MUC1. Results : IPMT was located largely in the head, and showed connection with the main pancreatic duct (MPD, 68.1%), no ovarian-like stroma (0/72), and presence of intervening intratumoral normal or atrophic parenchyma. On the other hand, MCT was located largely in the tail (73%), and showed common ovarian-like stroma (66/80), rare connection with the MPD (7/85) and no intervening pancreatic parenchyma. CEA and p53 immunoexpressions were significantly increased from adenoma through borderline to carcinoma, but MUC 1 was expressed only in the invasive carcinoma among cases of MCT and IPMT. Conclusions : The tumor location, ovarian-like stroma, connection with the MPD and intratumoral intervening nonneoplastic tissue were helpful in the differential diagnosis between IPMT and MCT. CEA and p53 expressions can be indicators of malignancy, while MUC 1 expression can indicate invasion.

[1]  日本膵臓学会 Classification of pancreatic carcinoma , 2003 .

[2]  J. Lüttges,et al.  The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.

[3]  T. Nagasaka,et al.  Problems in histological diagnosis of intraductal papillary-mucinous tumor (IPMT). , 2001, Hepato-gastroenterology.

[4]  D. Farley,et al.  Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. , 2001, The Surgical clinics of North America.

[5]  J. Zhao,et al.  An immunostaining panel for diagnosis of malignancy in mucinous tumors of the pancreas. , 2001, Archives of pathology & laboratory medicine.

[6]  Mais,et al.  The incidence of intraductal papillary mucinous tumors of the pancreas(1). , 2000, Current surgery.

[7]  A. Sauvanet,et al.  Intraductal Papillary Mucinous Tumors of the Pancreas Confined to Secondary Ducts Show Less Aggressive Pathologic Features as Compared With Those Involving the Main Pancreatic Duct , 2000, The American journal of surgical pathology.

[8]  N. Tanaka,et al.  Diagnosis and management of cystic pancreatic tumours with mucin production , 2000, The British journal of surgery.

[9]  H. Kawahira,et al.  p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. , 2000, Hepato-gastroenterology.

[10]  E. Dimagno,et al.  Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? , 2000, Annals of surgery.

[11]  D. Olive,et al.  Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples. , 1999, American journal of clinical pathology.

[12]  T. Nikaido,et al.  Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma , 1999, American Journal of Gastroenterology.

[13]  S. Kondo,et al.  Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas--diagnostic and biologic significance. , 1999, Hepato-gastroenterology.

[14]  E. Paal,et al.  A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  A. Scarpa,et al.  Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. , 1999, The American journal of surgical pathology.

[16]  J. Hecht,et al.  Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. , 1999, Human pathology.

[17]  T. Mattfeldt,et al.  Intraductal papillary mucinous tumor of the pancreas. , 1999, American journal of surgery.

[18]  R. Becker,et al.  Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. , 1999, The American journal of surgical pathology.

[19]  S. Takao,et al.  MUC‐1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas , 1998, Pathology international.

[20]  S. Yonezawa,et al.  Expression of mucin antigens in human cancers and its relationship with malignancy potential , 1997, Pathology international.

[21]  T. Hasebe,et al.  Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. , 1997, Human pathology.

[22]  T. Terada,et al.  EXPRESSION OF MUC APOMUCINS IN NORMAL PANCREAS AND PANCREATIC TUMOURS , 1996, The Journal of pathology.

[23]  T. Terada,et al.  Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas. , 1996, American journal of clinical pathology.

[24]  T. Terada,et al.  Immunohistochemical study of carcinoembryonic antigen in mucinous cystic neoplasm of the pancreas. , 1992, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[25]  B. Helpap,et al.  Immunohistochemical studies on cystic pancreatic neoplasms. , 1988, Pathology, research and practice.